牛叉诊股

[{"date":"2026.05.15","stock":"-1.14","trade":"-0.71","ind":"-1.17"},{"date":"2026.05.14","stock":"4.83","trade":"-1.71","ind":"-2.14"},{"date":"2026.05.13","stock":"2.03","trade":"-0.44","ind":"1.67"},{"date":"2026.05.12","stock":"-2.93","trade":"-1.41","ind":"-0.47"},{"date":"2026.05.11","stock":"3.02","trade":"1.65","ind":"2.16"},{"date":"2026.05.08","stock":"-4.28","trade":"0.14","ind":"-0.50"},{"date":"2026.05.07","stock":"1.62","trade":"-0.07","ind":"1.18"},{"date":"2026.05.06","stock":"1.45","trade":"0.78","ind":"2.33"},{"date":"2026.04.30","stock":"0.42","trade":"0.52","ind":"-0.09"},{"date":"2026.04.29","stock":"9.31","trade":"0.65","ind":"1.96"},{"date":"2026.04.28","stock":"-5.06","trade":"-0.61","ind":"-1.10"},{"date":"2026.04.27","stock":"-0.66","trade":"0.54","ind":"0.37"},{"date":"2026.04.24","stock":"-5.11","trade":"-0.33","ind":"-0.69"},{"date":"2026.04.23","stock":"1.96","trade":"-1.30","ind":"-0.88"},{"date":"2026.04.22","stock":"0.76","trade":"0.43","ind":"1.30"},{"date":"2026.04.21","stock":"-0.28","trade":"-0.98","ind":"0.10"},{"date":"2026.04.20","stock":"0.04","trade":"-0.37","ind":"0.55"},{"date":"2026.04.17","stock":"-0.44","trade":"-1.46","ind":"0.60"},{"date":"2026.04.16","stock":"-6.39","trade":"-0.14","ind":"2.05"},{"date":"2026.04.15","stock":"6.25","trade":"2.24","ind":"-0.97"},{"date":"2026.04.14","stock":"3.67","trade":"0.68","ind":"1.61"}]

广生堂,深证成指,化学制药指数

压力支撑

该股压力位为122.66元，支撑位为118.10元。

[{"text":"\u538b\u529b\u4f4d","value":"122.66","date":1778774400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"118.10","date":1778774400,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.0资金面打败了45%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：05月15日 20:30

机构今日流向(万元)	-1597.30	机构5日流向(万元)	-8128.52
机构10日流向(万元)	-13257.70	机构20日流向(万元)	-27793.92

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加282.55万股，其中基金净减仓4家，主力净增仓35家，请投资者中长期谨慎为宜。

截止2025-12-31，共66家主力机构（QFII2家，基金59家，一般法人4家，社保基金1家），持仓量总计5155.46万股，占流通A股37.71%
其中，基金持仓与2025-06-30相比：
增仓：5家，增持 3.58万股
减仓：9家，减持 272.58万股
新出现在主力名单中：47家，持有631.21万股
从主力名单中消失：12家，原持有130.94万股

消息面诊股

诊断结果：4.4消息面打败了4%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-04-29
一般消息	分红转增	不分配不转增	2026-04-29
重大利空	业绩预告	预计增亏	2026-01-31
一般消息	高管变动	取消监事会	2025-11-21
一般消息	分红转增	不分配不转增	2025-08-22

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	1条	0条

行业面诊股

诊断结果：2.5行业面打败了20%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.05.15","price":"-1.17","value":"-1.71"},{"date":"2026.05.14","price":"-2.14","value":"-0.44"},{"date":"2026.05.13","price":"1.67","value":"-1.41"},{"date":"2026.05.12","price":"-0.47","value":"1.65"},{"date":"2026.05.11","price":"2.16","value":"0.14"},{"date":"2026.05.08","price":"-0.50","value":"-0.07"},{"date":"2026.05.07","price":"1.18","value":"0.78"},{"date":"2026.05.06","price":"2.33","value":"0.52"},{"date":"2026.04.30","price":"-0.09","value":"0.65"},{"date":"2026.04.29","price":"1.96","value":"-0.61"},{"date":"2026.04.28","price":"-1.10","value":"0.54"},{"date":"2026.04.27","price":"0.37","value":"-0.33"},{"date":"2026.04.24","price":"-0.69","value":"-1.30"},{"date":"2026.04.23","price":"-0.88","value":"0.43"},{"date":"2026.04.22","price":"1.30","value":"-0.98"},{"date":"2026.04.21","price":"0.10","value":"-0.37"},{"date":"2026.04.20","price":"0.55","value":"-1.46"},{"date":"2026.04.17","price":"0.60","value":"-0.14"},{"date":"2026.04.16","price":"2.05","value":"2.24"},{"date":"2026.04.15","price":"-0.97","value":"0.68"},{"date":"2026.04.14","price":"1.61","value":"-0.85"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	昂利康	41.92%	35.18%	5.8分
2	宏源药业	35.30%	10.47%	6.0分
3	南新制药	34.00%	14.79%	5.1分
4	博瑞医药	29.80%	-6.41%	5.1分
5	共同药业	27.41%	-3.21%	5.8分
6	多瑞医药	25.90%	-1.44%	5.0分
7	仟源医药	22.89%	3.36%	6.2分
8	司太立	21.40%	14.33%	5.3分
9	溢多利	17.45%	1.36%	6.0分
10	德展健康	15.45%	3.13%	4.8分
11	东亚药业	14.67%	8.25%	6.3分
12	尔康制药	14.04%	4.84%	4.9分
13	前沿生物	13.31%	1.38%	5.6分
14	上海谊众	13.27%	4.67%	5.8分
15	金石亚药	13.08%	-0.86%	5.7分
16	一品红	12.99%	-1.86%	5.1分
17	津药药业	12.70%	16.83%	5.8分
18	贝达药业	12.66%	-1.73%	5.6分
19	翰宇药业	10.14%	14.29%	5.6分
20	ST景峰	9.66%	8.45%	4.9分
21	纳微科技	8.67%	1.08%	5.9分
22	威尔药业	8.30%	-0.07%	6.6分
23	海正药业	7.83%	-3.38%	5.0分
24	广济药业	6.20%	-3.03%	5.1分
25	ST天圣	5.89%	-3.58%	5.3分
26	奥赛康	5.60%	-5.30%	6.0分
27	赛托生物	5.43%	-3.92%	6.2分
28	河化股份	5.34%	2.45%	5.8分
29	悦康药业	4.69%	-7.62%	5.1分
30	百济神州	4.11%	1.83%	5.7分
31	广生堂	4.04%	5.75%	5.2分
32	泽璟制药	3.92%	0.89%	5.8分
33	-	3.44%	-1.73%	分
34	首药控股	3.19%	0.24%	5.5分
35	通化金马	2.79%	-8.46%	4.3分
36	华海药业	2.67%	0.43%	6.0分
37	三圣股份	2.58%	-5.36%	5.2分
38	西点药业	2.53%	-4.33%	5.8分
39	莱美药业	2.43%	0.96%	4.8分
40	民生健康	2.35%	-3.16%	5.2分
41	-	2.23%	-2.42%	分
42	本立科技	2.12%	-4.07%	5.3分
43	ST复华	1.97%	0.43%	5.0分
44	-	1.91%	-3.57%	分
45	科源制药	1.79%	-4.50%	5.2分
46	益方生物	1.70%	-2.71%	4.5分
47	金城医药	1.60%	-1.00%	5.9分
48	汇宇制药	1.57%	-0.59%	5.8分
49	-	1.36%	-2.95%	分
50	向日葵	1.27%	-1.48%	4.5分
51	ST诺泰	1.16%	-2.52%	4.9分
52	-	0.76%	-3.09%	分
53	美诺华	-0.31%	-20.25%	4.4分
54	鲁抗医药	-0.48%	-2.48%	5.1分
55	罗欣药业	-0.58%	-6.39%	5.0分
56	华纳药厂	-0.85%	-7.34%	4.9分
57	-	-1.16%	-3.87%	分
58	康芝药业	-1.32%	-1.84%	4.7分
59	哈三联	-1.39%	-1.81%	5.1分
60	复旦张江	-1.39%	-2.86%	5.4分
61	-	-1.39%	-2.80%	分
62	ST人福	-1.83%	-1.41%	4.8分
63	兴齐眼药	-1.92%	-4.51%	4.6分
64	ST惠程	-1.95%	-1.71%	4.7分
65	微芯生物	-2.01%	-3.33%	5.4分
66	赛分科技	-2.04%	-0.76%	6.1分
67	新诺威	-2.19%	-4.05%	5.3分
68	新华制药	-2.59%	-0.69%	4.8分
69	-	-2.62%	-3.02%	分
70	宣泰医药	-2.75%	-3.36%	5.6分
71	仙琚制药	-2.79%	-1.47%	5.5分
72	圣诺生物	-2.98%	-2.64%	4.6分
73	奥翔药业	-3.18%	-0.79%	5.0分
74	华润双鹤	-3.30%	-2.01%	5.0分
75	卫信康	-3.36%	-4.28%	5.4分
76	泰恩康	-3.69%	-4.24%	4.4分
77	川宁生物	-3.85%	-3.85%	5.0分
78	普洛药业	-3.88%	-5.25%	4.6分
79	恒瑞医药	-3.90%	2.25%	5.9分
80	诚意药业	-4.02%	-6.75%	4.9分
81	拓新药业	-4.13%	-10.00%	4.1分
82	灵康药业	-4.17%	-3.53%	5.7分
83	花园生物	-4.55%	-2.96%	4.0分
84	健康元	-4.81%	-2.51%	4.6分
85	富士莱	-4.89%	-1.36%	5.5分
86	莎普爱思	-5.04%	-4.62%	4.7分
87	天新药业	-5.08%	-1.99%	5.1分
88	艾力斯	-5.23%	-2.28%	5.7分
89	海创药业	-5.37%	-3.81%	5.5分
90	永安药业	-5.43%	-6.85%	5.1分
91	丰原药业	-5.49%	-3.88%	5.3分
92	汉商集团	-5.49%	-4.83%	4.9分
93	恩华药业	-5.59%	-3.61%	4.8分
94	国药现代	-5.61%	-3.64%	5.0分
95	-	-5.80%	-2.52%	分
96	福安药业	-6.15%	-3.87%	4.5分
97	常山药业	-6.28%	-9.09%	4.9分
98	润都股份	-6.43%	-6.57%	5.0分
99	华仁药业	-6.85%	-3.24%	5.3分
100	华邦健康	-7.20%	-2.05%	4.5分
101	科伦药业	-7.21%	-5.40%	4.6分
102	小方制药	-7.29%	-4.47%	4.1分
103	山河药辅	-7.45%	-3.90%	4.1分
104	海欣股份	-7.75%	-9.90%	4.8分
105	北大医药	-7.80%	-8.55%	4.1分
106	亨迪药业	-7.88%	-4.39%	5.0分
107	迪哲医药	-7.93%	-1.84%	4.9分
108	新天地	-7.95%	-4.86%	4.7分
109	易明医药	-8.28%	-4.02%	5.4分
110	东北制药	-8.44%	-1.61%	4.9分
111	华特达因	-8.52%	-2.07%	5.2分
112	国邦医药	-8.59%	0.60%	5.5分
113	辰欣药业	-8.63%	-5.42%	4.3分
114	华北制药	-8.68%	-3.81%	4.2分
115	丽珠集团	-8.77%	-3.59%	4.6分
116	复星医药	-8.81%	-2.78%	4.3分
117	海普瑞	-8.82%	-4.96%	5.1分
118	必贝特	-8.87%	2.74%	6.2分
119	同和药业	-9.01%	-5.99%	5.2分
120	金陵药业	-9.45%	-6.59%	5.0分
121	海思科	-9.50%	-3.32%	6.1分
122	凯因科技	-9.58%	-4.58%	4.3分
123	浙江医药	-9.64%	-0.84%	4.9分
124	立方制药	-9.87%	-6.33%	5.2分
125	哈药股份	-9.90%	-3.19%	4.5分
126	联环药业	-10.01%	-7.05%	4.7分
127	健友股份	-10.12%	-4.40%	5.1分
128	华东医药	-10.57%	-5.89%	4.8分
129	海森药业	-10.95%	0.09%	4.3分
130	京新药业	-11.05%	-5.32%	4.9分
131	东诚药业	-11.18%	-3.83%	4.7分
132	亚太药业	-11.37%	-4.34%	4.1分
133	千红制药	-11.51%	-2.40%	4.5分
134	亚虹医药	-11.53%	-3.62%	4.5分
135	神奇制药	-11.78%	-4.97%	5.6分
136	海辰药业	-11.87%	-8.99%	4.4分
137	亿帆医药	-12.04%	-2.33%	4.8分
138	九典制药	-12.07%	-4.72%	4.2分
139	键凯科技	-12.15%	-5.25%	5.1分
140	盟科药业	-12.68%	-7.64%	4.4分
141	苑东生物	-12.87%	-7.98%	5.3分
142	福元医药	-13.02%	-5.17%	5.3分
143	舒泰神	-13.24%	-2.83%	4.8分
144	新和成	-13.75%	1.95%	5.3分
145	富祥股份	-13.89%	-7.89%	4.5分
146	北陆药业	-14.12%	-6.58%	5.1分
147	百利天恒	-14.15%	-3.29%	4.8分
148	海南海药	-14.55%	-9.31%	4.0分
149	誉衡药业	-14.86%	-5.12%	5.1分
150	ST能特	-15.10%	6.75%	4.3分
151	中关村	-15.28%	-4.47%	5.3分
152	吉贝尔	-15.33%	-4.82%	4.8分
153	天宇股份	-15.69%	-6.37%	4.7分
154	力生制药	-15.80%	-3.39%	5.0分
155	双鹭药业	-16.76%	-6.00%	3.8分
156	奥锐特	-19.14%	-5.95%	4.9分
157	海翔药业	-21.25%	-7.05%	4.8分
158	*ST赛隆	-28.14%	-22.65%	4.6分
159	信立泰	-43.33%	-26.41%	4.9分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.5基本面打败了6%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 146/219 ， 38/219。

[{"date":"2026-03-31","value":"-9.80","vol":"0.43"},{"date":"2025-12-31","value":"-68.32","vol":"-2.03"},{"date":"2025-09-30","value":"-30.03","vol":"1.53"},{"date":"2025-06-30","value":"-20.43","vol":"1.24"},{"date":"2025-03-31","value":"-8.24","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-9.80	-68.32	-30.03	-20.43	-8.24
行业(%)	0.43	-2.03	1.53	1.24	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"66.95","vol":"50.72"},{"date":"2025-12-31","value":"62.32","vol":"49.72"},{"date":"2025-09-30","value":"61.91","vol":"49.60"},{"date":"2025-06-30","value":"61.09","vol":"49.57"},{"date":"2025-03-31","value":"65.63","vol":"49.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	66.95	62.32	61.91	61.09	65.63
行业(%)	50.72	49.72	49.60	49.57	49.06

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 72/219 ， 62/219。

[{"date":"2026-03-31","value":"0.85","vol":"25.51"},{"date":"2025-12-31","value":"-5.68","vol":"38.97"},{"date":"2025-09-30","value":"-3.21","vol":"141.63"},{"date":"2025-06-30","value":"-4.27","vol":"78.56"},{"date":"2025-03-31","value":"-18.69","vol":"0.01"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	0.85	-5.68	-3.21	-4.27	-18.69
行业(%)	25.51	38.97	141.63	78.56	0.01

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"9.00","vol":"47.13"},{"date":"2025-12-31","value":"-39.37","vol":"-26.11"},{"date":"2025-09-30","value":"-57.96","vol":"-2.93"},{"date":"2025-06-30","value":"-85.05","vol":"59.61"},{"date":"2025-03-31","value":"-94.56","vol":"-10.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	9.00	-39.37	-57.96	-85.05	-94.56
行业(%)	47.13	-26.11	-2.93	59.61	-10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 107/219 ， 127/219。

[{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.29","vol":"0.41"},{"date":"2025-09-30","value":"0.21","vol":"0.31"},{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.07","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.07	0.29	0.21	0.15	0.07
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.26","vol":"0.65"},{"date":"2025-12-31","value":"1.31","vol":"2.58"},{"date":"2025-09-30","value":"0.93","vol":"1.93"},{"date":"2025-06-30","value":"0.62","vol":"1.29"},{"date":"2025-03-31","value":"0.28","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.26	1.31	0.93	0.62	0.28
行业(次)	0.65	2.58	1.93	1.29	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-20.41","vol":"-2.81"},{"date":"2025-12-31","value":"10.01","vol":"16.49"},{"date":"2025-09-30","value":"-24.06","vol":"4.26"},{"date":"2025-06-30","value":"-6.13","vol":"2.95"},{"date":"2025-03-31","value":"-12.86","vol":"-26.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-20.41	10.01	-24.06	-6.13	-12.86
行业	-2.81	16.49	4.26	2.95	-26.33

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.60","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.30","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.60	-	0.30	-
行业	0.00	1.60	0.00	1.71	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 72/219 ， 42/219。

[{"date":"2026-03-31","value":"1.02","vol":"3.57"},{"date":"2025-12-31","value":"1.08","vol":"3.31"},{"date":"2025-09-30","value":"1.03","vol":"3.48"},{"date":"2025-06-30","value":"0.67","vol":"3.66"},{"date":"2025-03-31","value":"0.69","vol":"3.57"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.02	1.08	1.03	0.67	0.69
行业	3.57	3.31	3.48	3.66	3.57

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.61","vol":"2.93"},{"date":"2025-12-31","value":"0.64","vol":"2.69"},{"date":"2025-09-30","value":"0.62","vol":"2.73"},{"date":"2025-06-30","value":"0.30","vol":"2.88"},{"date":"2025-03-31","value":"0.35","vol":"2.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.61	0.64	0.62	0.30	0.35
行业	2.93	2.69	2.73	2.88	2.80

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 93/219 ， 4/219。

[{"date":"2026-03-31","value":"77.64","vol":"33.54"},{"date":"2025-12-31","value":"75.27","vol":"34.70"},{"date":"2025-09-30","value":"69.18","vol":"34.06"},{"date":"2025-06-30","value":"76.15","vol":"34.12"},{"date":"2025-03-31","value":"73.45","vol":"34.09"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	77.64	75.27	69.18	76.15	73.45
行业(%)	33.54	34.70	34.06	34.12	34.09

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"4.36","vol":"9.77"},{"date":"2025-12-31","value":"3.80","vol":"1.76"},{"date":"2025-09-30","value":"2.74","vol":"1.19"},{"date":"2025-06-30","value":"3.55","vol":"0.87"},{"date":"2025-03-31","value":"3.06","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	4.36	3.80	2.74	3.55	3.06
行业(%)	9.77	1.76	1.19	0.87	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"-1.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.49","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-2.18","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[广生堂]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]